NCT07210047 2025-10-07Study of HuL001 in Relapsed/Refractory Multiple Myeloma PatientsHuniLife Biotechnology, Inc.Phase 1/2 Enrolling by invitation21 enrolled
NCT06762431 2025-01-07VTB-CLL002Vitebsk Regional Clinical Cancer CentrePhase 1/2 Enrolling by invitation60 enrolled